keyword
https://read.qxmd.com/read/38564451/efficacy-and-safety-of-bleselumab-in-preventing-the-recurrence-of-primary-focal-segmental-glomerulosclerosis-in-kidney-transplant-recipients-a-phase-2a-randomized-multicenter-study
#21
JOURNAL ARTICLE
Jun Shoji, William C Goggins, Jason R Wellen, Patrick N Cunningham, Olwyn Johnston, Shirley S Chang, Kim Solez, Vicki Santos, Tami J Larson, Masahiro Takeuchi, Xuegong Wang
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease and frequently recurs after kidney transplantation. Recurrent FSGS (rFSGS) is associated with poor allograft and patient outcomes. Bleselumab, a fully human immunoglobulin G4 anti-CD40 antagonistic monoclonal antibody, disrupts CD40-related processes in FSGS, potentially preventing rFSGS. METHODS: A phase 2a, randomized, multicenter, open-label study of adult recipients (aged ≥18 y) of a living or deceased donor kidney transplant with a history of biopsy-proven primary FSGS...
April 1, 2024: Transplantation
https://read.qxmd.com/read/38564053/progressive-demyelinating-polyneuropathy-after-hematopoietic-cell-transplantation-in-metachromatic-leukodystrophy-a-case-series
#22
JOURNAL ARTICLE
Shanice Beerepoot, Jaap Jan Boelens, Caroline Lindemans, Moniek A de Witte, Stefan Nierkens, Alexander F J E Vrancken, Marjo S van der Knaap, Marianna Bugiani, Nicole I Wolf
Metachromatic leukodystrophy (MLD) is a neuro-metabolic disorder due to arylsulfatase A deficiency, causing demyelination of the central and peripheral nervous system. Hematopoietic cell transplantation (HCT) can provide a symptomatic and survival benefit for pre-symptomatic and early symptomatic patients by stabilizing CNS disease. This case series, however, illustrates the occurrence of severely progressive polyneuropathy shortly after HCT in two patients with late-infantile, one with late-juvenile, and one with adult MLD, leading to the inability to walk or sit without support...
April 2, 2024: Journal of Neurology
https://read.qxmd.com/read/38563679/risk-factors-for-initial-and-recurrent-severe-infections-in-first-hospitalized-patients-with-systemic-lupus-erythematosus-a-retrospective-study-of-a-chinese-cohort
#23
JOURNAL ARTICLE
Ying Zhu, Kexin Zhu, Xueyi Zhang, Zhijie Qian, Qingqing Guo, Xuefeng Xu, Genhong Yao, Xiaojun Tang, Dandan Wang, Huayong Zhang, Xuebing Feng, Ziyi Jin, Lingyun Sun
OBJECTIVE: To evaluate the incidence and associated factors of initial and recurrent severe infections in hospitalized patients with systemic lupus erythematosus (SLE). METHODS: SLE patients that first hospitalized between 2010 and 2021 were studied retrospectively and divided into SLE with and without baseline severe infection groups. The primary outcome was the occurrence of severe infection during follow-up. Cox regression models were used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for initial and recurrent severe infections...
April 2024: International Journal of Rheumatic Diseases
https://read.qxmd.com/read/38553270/disease-modifying-treatments-for-neuromyelitis-optica-spectrum-disorder-in-the-context-of-a-new-generation-of-biotherapies
#24
REVIEW
S Demuth, N Collongues
Neuromyelitis optica spectrum disorder (NMOSD) is a rare but debilitating autoimmune disease of the central nervous system (CNS) for which several biotherapies have recently been approved on the market. Historically, NMOSD disease-modifying treatments relied on wide-spectrum off-label immunosuppressants, such as azathioprine, mycophenolate mofetil, and cyclophosphamide. Since 2015, evidence has accumulated to support off-label biotherapies (rituximab and tocilizumab) and to approve satralizumab, inebilizumab, eculizumab, and ravulizumab...
March 28, 2024: Revue Neurologique
https://read.qxmd.com/read/38546424/multiple-sclerosis-associated-uveitis-a-case-report-of-refractory-bilateral-chronic-granulomatous-panuveitis-successfully-treated-with-tocilizumab
#25
JOURNAL ARTICLE
William Gil, Hassan Lagrib, Louis Olagne, Céline Tilignac, Maud Perie, Frédéric Taithe, Xavier Moisset, Frederic Chiambaretta, Pierre Clavelou, Marc Andre, Ludovic Trefond
PURPOSE: To report a case of uveitis associated with multiple sclerosis (MS) that was refractory to multiple lines of therapy but achieved remission with tocilizumab. METHODS: We conducted a retrospective analysis of the patient's medical record including clinical, biological and imaging data. RESULTS: A 33-year-old female patient with a history of MS inactive for 5 years on teriflunomide, and no significant medical or ophthalmological history, presented with bilateral granulomatous panuveitis...
March 28, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38545728/predictive-factors-of-renal-graft-failure-in-tunisian-children-and-young-adults-a-retrospective-study
#26
JOURNAL ARTICLE
Abir Boussetta, Manel Jellouli, Tahar Gargah, Meriem Hajji, Hafedh Hedri, Ezzeddine Abderrahim
INTRODUCTION: Pediatric end-stage renal disease is a rare but severe condition that causes numerous complications and impairs the quality of life of children. Kidney transplantation is the therapy of choice in pediatric end-stage renal disease. AIM: Our study aimed to identify the predictive factors of renal graft failure after kidney transplantation in Tunisian children and young adults. METHODS: We conducted a retrospective bicentric study of children and young adults (age≤20 years) who had undergone renal transplantation between 1989 and 2019 in Tunisia...
January 5, 2024: La Tunisie Médicale
https://read.qxmd.com/read/38545489/effectiveness-and-tolerability-of-systemic-therapies-in-oral-lichen-planus-a-retrospective-cohort-study
#27
JOURNAL ARTICLE
Emma L Myers, Alison N Hollis, Donna A Culton
No abstract text is available yet for this article.
June 2024: JAAD international
https://read.qxmd.com/read/38543908/impact-of-immunomodulatory-therapy-on-covid-19-vaccine-response-in-patients-with-autoimmune-inflammatory-rheumatic-diseases
#28
REVIEW
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, Joel Jia Wei Ng, Dan Xu, Shuo Feng, Rong Mu, Bernard Yu-Hor Thong, Chuanhui Xu
Coronavirus disease 2019 (COVID-19) vaccination is essential for patients with autoimmune inflammatory rheumatic diseases (AIIRD) to reduce the risk of morbidity and mortality associated with serious COVID-19 infection. With endemicity, waning of vaccine- and infection-acquired immunity, and development of SARS-CoV-2 variants, the need for additional doses of vaccines against serious illness in high-risk immunocompromised persons remains imperative. This review examines how immunomodulatory therapies affect vaccine-induced immune response in patients with AIIRD...
March 6, 2024: Vaccines
https://read.qxmd.com/read/38533933/data-mining-and-safety-analysis-of-traditional-immunosuppressive-drugs-a-pharmacovigilance-investigation-based-on-the-faers-database
#29
JOURNAL ARTICLE
Juan-Juan Li, Li Chen, Yang Zhao, Xue-Qin Yang, Fa-Bin Hu, Li Wang
OBJECTIVE: The purpose of this study aimed to explore the new and serious adverse events(AEs) of Tacrolimus(FK506), cyclosporine(CsA), azathioprine(AZA), mycophenolate mofetil(MMF), cyclophosphamide(CTX) and methotrexate(MTX), which have not been concerned. METHODS: The FAERS data from January 2016 and December 2022 were selected for disproportionality analysis to discover the potential risks of traditional immunosuppressive drugs. RESULTS: Compared with CsA, FK506 has more frequent transplant rejection, and is more related to renal impairment, COVID-19, cytomegalovirus infection and aspergillus infection...
March 27, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38528676/correlations-between-serum-kidney-injury-molecule-1-cystatin-c-and-immunosuppressants-a-cross-sectional-study-of-renal-transplant-patients-in-bahrain
#30
JOURNAL ARTICLE
Kannan Sridharan, Shamik Shah, Mona Al Hammad, Fatima Ali Mohammed, Sindhan Veeramuthu, Mona Abdulla Taher, Mustafa Mohamed Hammad, Lamees Jawad, Eman Farid
Renal transplant patients receive several immunosuppressive drug regimens that are potentially nephrotoxic for treatment. Serum creatinine is the standard for monitoring kidney function; however, cystatin C (Cys C) and kidney injury molecule-1 (KIM-1) have been found to indicate kidney injury earlier than serum creatinine and provide a better reflection of kidney function. Here, we assessed Cys C and KIM-1 serum levels in renal transplant patients receiving mycophenolate mofetil, tacrolimus, sirolimus, everolimus, or cyclosporine to evaluate kidney function...
March 26, 2024: Journal of Biomedical Research
https://read.qxmd.com/read/38527841/-single-non-blood-related-umbilical-cord-blood-transplantation-using-a-reduced-intensity-conditioning-regimen-for-the-treatment-of-severe-aplastic-anemia
#31
JOURNAL ARTICLE
Y Wu, B L Tang, K D Song, G Y Sun, T Z Pan, A J Huang, B B Yan, X Y Zhu
Objective: To evaluated the clinical efficacy of a reduced-intensity preconditioning regimen for single non-blood-related umbilical cord blood transplantation (sUCBT) in the treatment of severe aplastic anemia (SAA) . Methods: The clinical data of 63 patients with SAA who underwent sUCBT from January 2021 to July 2023 at the Department of Hematology of the First Affiliated Hospital of USTC were retrospectively analyzed. Fifty-two patients received total body irradiation/total bone marrow irradiation (TMI) combined with fludarabine or a cyclophosphamide- conditioning regimen (non-rATG group) , while 11 patients received rabbit anti-human thymocyte immunoglobulin (rATG) combined with TMI, fludarabine, or the cyclophosphamide-conditioning regimen (rATG group) ...
January 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/38524729/telitacicept-treatment-refractory-lupus-nephritis-a-case-report
#32
Sijia Li, Shuting Deng, Sichun Wen, Siqi Peng, Nan Jiang, Bohou Li, Boxi Chen, Ye Yuan, Qiong Wu, Yiming Tao, Jianchao Ma, Ting Lin, Feng Wen, Zhuo Li, Hao Dai, Renwei Huang, Zhonglin Feng, Zhilian Li, Shuangxin Liu, Lixia Xu
INTRODUCTION: Refractory lupus nephritis (LN) causes kidney disease progression and increases the risk of loss of renal function. Due to the high specificity and few side effects of biological agents, they are recommended for the treatment of systemic lupus erythematosus. There are few data on telitacicept for the treatment of refractory LN. CASE PRESENTATION: Here, we report the efficacy and safety of telitacicept in the treatment of refractory LN in a 25-year-old female patient...
2024: Case Reports in Nephrology and Dialysis
https://read.qxmd.com/read/38519110/prediction-of-progressive-fibrosing-interstitial-lung-disease-in-patients-with-systemic-sclerosis-insight-from-the-crdc-cohort-study
#33
JOURNAL ARTICLE
Min Hui, Xinwang Duan, Jiaxin Zhou, Mengtao Li, Qian Wang, Jiuliang Zhao, Yong Hou, Dong Xu, Xiaofeng Zeng
BACKGROUND: This study aims to establish a reliable prediction model of progressive fibrosing interstitial lung disease (PF-ILD) in patients with systemic sclerosis (SSc)-ILD, to achieve early risk stratification and to help better in preventing disease progression. METHODS: 304 SSc-ILD patients with no less than three pulmonary function tests within 6-24 months were included. We collected data at baseline and compared differences between SSc patients with and without PF-ILD...
March 22, 2024: RMD Open
https://read.qxmd.com/read/38516185/a-gc-ms-based-untargeted-metabolomics-approach-for-comprehensive-metabolic-profiling-of-mycophenolate-mofetil-induced-toxicity-in-mice
#34
JOURNAL ARTICLE
Tongfeng Zhao, Yaxin Zhao, Haotian Chen, Wenxue Sun, Yun Guan
Background: Mycophenolate mofetil (MMF), the morpholinoethyl ester of mycophenolic acid, is widely used for maintenance immunosuppression in transplantation. The gastrointestinal toxicity of MMF has been widely uncovered. However, the comprehensive metabolic analysis of MMF-induced toxicity is lacking. This study is aimed to ascertain the metabolic changes after MMF administration in mice. Methods: A total of 700 mg MMF was dissolved in 7 mL dimethyl sulfoxide (DMSO), and then 0.5 mL of mixture was diluted with 4...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38514928/look-after-the-covid-19-pandemic-mortality-rates-among-patients-with-rheumatic-diseases
#35
JOURNAL ARTICLE
Ezgi Çimen Güneş, Seda Çolak, Zeynep B Şenlik, Emre Tekgöz, Kerime Altunay, Tuğba Özdemirkan, Baran C Aytaç, Asiye Ç Şimşek, Muhammet Çınar, Sedat Yılmaz
AIM: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection may have a more severe course in patients with underlying disease or who have had immunosuppression. In this study, it was aimed to determine the frequency of coronavirus disease 2019 (COVID-19) and the mortality rates related to COVID-19 among patients with rheumatic disease. METHODS: The patients who were followed up with rheumatic disease in the rheumatology outpatient clinic in a tertiary hospital were retrospectively assessed if they had COVID-19 infection or not between March 2020 and January 2022...
March 2024: International Journal of Rheumatic Diseases
https://read.qxmd.com/read/38514155/treatment-of-myopathy-and-cutaneous-ulcers-in-anti-mda5-positive-dermatomyositis-with-triple-therapy
#36
JOURNAL ARTICLE
Gopisree Peringeth, Bhavna Abbi, Shereen Mahmood
Antimelanoma differentiation-associated protein 5 positive dermatomyositis (MDA5 DM) is a rare subtype of idiopathic inflammatory myopathy. There are limited data available regarding the cutaneous manifestations of MDA5 DM in the African American population. We presented the case of a male patient in his early 20s who presented with debilitating cutaneous ulceration and myopathy. Workup revealed interstitial lung disease (ILD) and positive MDA5 serology consistent with MDA5 DM. He made a remarkable recovery in terms of myopathy and cutaneous ulcerations with a multipronged regimen of prednisone, intravenous immunoglobulin and mycophenolate mofetil...
March 21, 2024: BMJ Case Reports
https://read.qxmd.com/read/38510194/increased-levels-of-a-mycophenolic-acid-metabolite-in-patients-with-kidney-failure-negatively-affect-cardiomyocyte-health
#37
JOURNAL ARTICLE
Eva Harlacher, Corinna Schulte, Sonja Vondenhoff, Philippe Schmitt-Kopplin, Philippe Diederich, Christian Hemmers, Julia Moellmann, Julia Wollenhaupt, Rogier Veltrop, Erik Biessen, Michael Lehrke, Björn Peters, Georg Schlieper, Christoph Kuppe, Jürgen Floege, Vera Jankowski, Nikolaus Marx, Joachim Jankowski, Heidi Noels
Chronic kidney disease (CKD) significantly increases cardiovascular risk and mortality, and the accumulation of uremic toxins in the circulation upon kidney failure contributes to this increased risk. We thus performed a screening for potential novel mediators of reduced cardiovascular health starting from dialysate obtained after hemodialysis of patients with CKD. The dialysate was gradually fractionated to increased purity using orthogonal chromatography steps, with each fraction screened for a potential negative impact on the metabolic activity of cardiomyocytes using a high-throughput MTT-assay, until ultimately a highly purified fraction with strong effects on cardiomyocyte health was retained...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38509864/initiation-of-belimumab-with-higher-daily-prednisolone-is-effective-for-rapid-glucocorticoid-reduction-a-96-week-retrospective-study
#38
JOURNAL ARTICLE
Takashi Yamane, Akira Hashiramoto
OBJECTIVES: For appropriate glucocorticoid (GC) reduction, we investigated the optimal strategy including baseline factors that could reduce GC more than 50% with 96 weeks of belimumab. METHODS: This is a retrospective cohort study of Kakogawa Central City hospital from 2019 to 2023. We identified SLE patients who were receiving 200 mg of belimumab weekly by subcutaneous injection for 96 weeks. The background at baseline, trends in clinical indicators, and factors involved in GC reduction were statistically analyzed...
May 2024: Lupus
https://read.qxmd.com/read/38508914/the-25-hydroxyvitamin-d-level-in-kidney-transplant-recipients-and-its-association-with-renal-function-and-other-cardio-metabolic-risk-markers
#39
JOURNAL ARTICLE
M Masud Iqbal, Maleka Ali, Rana Mokarram Hossain, Md Kamrul Islam, Harun-Ur- Rashid, Shahryar Waheed, Nayan Ranjan Sarker
BACKGROUND: Vitamin D is the main hormone that plays a critical role in controlling mineral homeostasis. Transplant recipients frequently have altered levels of 25-hydroxyvitamin D (25[OH] D) and 1, 25-hydroxyvitamin (1, 25[OH] D). OBJECTIVES: To explore the status of vitamin D level in renal allograft recipients and its association with renal function and cardio-metabolic risk markers. METHODS: One hundred two adult kidney transplant recipients (KTRs) were included...
March 19, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38507959/an-atypical-association-of-lichen-planus-pigmentosus-and-bullous-lichen-planus
#40
JOURNAL ARTICLE
M Bouquerel, E Baubion, L Dufrenot Petitjean Roget, E Amazan, N Olivier
No abstract text is available yet for this article.
March 19, 2024: Annales de Dermatologie et de Vénéréologie
keyword
keyword
51015
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.